Research and Production Enterprise "Technologiya" of Rostec State Corporation, together with the National Medical Research Center of Radiology, have developed a device for brachytherapy, which increases the effectiveness of radiation therapy for malignant tumors. The product is manufactured using additive technologies and outperforms analogues on the medical equipment market.
The device provides more precise positioning of brachytherapy needles used for point implantation of radioactive microsources into the tumor or tissue around it. Thanks to the use of 3D printing technology, the new product provides 25 positioning channels per square centimeter - 25% more than imported counterparts, which increases the accuracy of implantation and the effectiveness of treatment.
“The development was carried out by ‘Technologiya’ in cooperation with the National Medical Research Center of Radiology. The device significantly improves the positioning accuracy of brachytherapy needles and the efficiency of operations on complex malignant tumors. The new product is made of an alloy of cobalt and chromium and, unlike analogs made of plastic and metals subject to oxidation, it can be reused many times”, said Oleg Yevtushenko, executive director of Rostec.
The device is designed for brachytherapy of malignant tumors in the pelvic area. It is planned to create similar devices for the treatment of tumors affecting other parts of the body.